Male hypogonadism, also known as testosterone deficiency, is a failure of the testes to produce the?male?sex hormone testosterone, sperm, or both. It can be due to a testicular disorder or the result of a disease process involving the hypothalamus and pituitary gland.
This report aims to provide a comprehensive presentation of the global market for Male Hypogonadism Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Male Hypogonadism Therapy. This report contains market size and forecasts of Male Hypogonadism Therapy in global, including the following market information:
Global Male Hypogonadism Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Male Hypogonadism Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Parenteral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Male Hypogonadism Therapy include Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck KGaA, Mylan, Bayer, Teva and Novartis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Male Hypogonadism Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Male Hypogonadism Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Male Hypogonadism Therapy Market Segment Percentages, by Type, 2022 (%)
Parenteral
Transdermal
Oral
Others
Global Male Hypogonadism Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Male Hypogonadism Therapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Drugstores
Others
Global Male Hypogonadism Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Male Hypogonadism Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Male Hypogonadism Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Male Hypogonadism Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Pfizer
AbbVie
Novo Nordisk
Merck KGaA
Mylan
Bayer
Teva
Novartis
Abbott
Roche
Endo International
Ipsen
ANI Pharmaceuticals
TherapeuticsMD
Outline of Major Chapters:
Chapter 1: Introduces the definition of Male Hypogonadism Therapy, market overview.
Chapter 2: Global Male Hypogonadism Therapy market size in revenue.
Chapter 3: Detailed analysis of Male Hypogonadism Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Male Hypogonadism Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Male Hypogonadism Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Male Hypogonadism Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Male Hypogonadism Therapy Overall Market Size
2.1 Global Male Hypogonadism Therapy Market Size: 2022 VS 2029
2.2 Global Male Hypogonadism Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Male Hypogonadism Therapy Players in Global Market
3.2 Top Global Male Hypogonadism Therapy Companies Ranked by Revenue
3.3 Global Male Hypogonadism Therapy Revenue by Companies
3.4 Top 3 and Top 5 Male Hypogonadism Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Male Hypogonadism Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Male Hypogonadism Therapy Players in Global Market
3.6.1 List of Global Tier 1 Male Hypogonadism Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Male Hypogonadism Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Male Hypogonadism Therapy Market Size Markets, 2022 & 2029
4.1.2 Parenteral
4.1.3 Transdermal
4.1.4 Oral
4.1.5 Others
4.2 By Type - Global Male Hypogonadism Therapy Revenue & Forecasts
4.2.1 By Type - Global Male Hypogonadism Therapy Revenue, 2018-2023
4.2.2 By Type - Global Male Hypogonadism Therapy Revenue, 2024-2029
4.2.3 By Type - Global Male Hypogonadism Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Male Hypogonadism Therapy Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Drugstores
5.1.4 Others
5.2 By Application - Global Male Hypogonadism Therapy Revenue & Forecasts
5.2.1 By Application - Global Male Hypogonadism Therapy Revenue, 2018-2023
5.2.2 By Application - Global Male Hypogonadism Therapy Revenue, 2024-2029
5.2.3 By Application - Global Male Hypogonadism Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Male Hypogonadism Therapy Market Size, 2022 & 2029
6.2 By Region - Global Male Hypogonadism Therapy Revenue & Forecasts
6.2.1 By Region - Global Male Hypogonadism Therapy Revenue, 2018-2023
6.2.2 By Region - Global Male Hypogonadism Therapy Revenue, 2024-2029
6.2.3 By Region - Global Male Hypogonadism Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Male Hypogonadism Therapy Revenue, 2018-2029
6.3.2 US Male Hypogonadism Therapy Market Size, 2018-2029
6.3.3 Canada Male Hypogonadism Therapy Market Size, 2018-2029
6.3.4 Mexico Male Hypogonadism Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Male Hypogonadism Therapy Revenue, 2018-2029
6.4.2 Germany Male Hypogonadism Therapy Market Size, 2018-2029
6.4.3 France Male Hypogonadism Therapy Market Size, 2018-2029
6.4.4 U.K. Male Hypogonadism Therapy Market Size, 2018-2029
6.4.5 Italy Male Hypogonadism Therapy Market Size, 2018-2029
6.4.6 Russia Male Hypogonadism Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Male Hypogonadism Therapy Market Size, 2018-2029
6.4.8 Benelux Male Hypogonadism Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Male Hypogonadism Therapy Revenue, 2018-2029
6.5.2 China Male Hypogonadism Therapy Market Size, 2018-2029
6.5.3 Japan Male Hypogonadism Therapy Market Size, 2018-2029
6.5.4 South Korea Male Hypogonadism Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Male Hypogonadism Therapy Market Size, 2018-2029
6.5.6 India Male Hypogonadism Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Male Hypogonadism Therapy Revenue, 2018-2029
6.6.2 Brazil Male Hypogonadism Therapy Market Size, 2018-2029
6.6.3 Argentina Male Hypogonadism Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Male Hypogonadism Therapy Revenue, 2018-2029
6.7.2 Turkey Male Hypogonadism Therapy Market Size, 2018-2029
6.7.3 Israel Male Hypogonadism Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Male Hypogonadism Therapy Market Size, 2018-2029
6.7.5 UAE Male Hypogonadism Therapy Market Size, 2018-2029
7 Male Hypogonadism Therapy Companies Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Company Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Male Hypogonadism Therapy Major Product Offerings
7.1.4 Eli Lilly Male Hypogonadism Therapy Revenue in Global Market (2018-2023)
7.1.5 Eli Lilly Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Male Hypogonadism Therapy Major Product Offerings
7.2.4 Pfizer Male Hypogonadism Therapy Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Male Hypogonadism Therapy Major Product Offerings
7.3.4 AbbVie Male Hypogonadism Therapy Revenue in Global Market (2018-2023)
7.3.5 AbbVie Key News & Latest Developments
7.4 Novo Nordisk
7.4.1 Novo Nordisk Company Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Male Hypogonadism Therapy Major Product Offerings
7.4.4 Novo Nordisk Male Hypogonadism Therapy Revenue in Global Market (2018-2023)
7.4.5 Novo Nordisk Key News & Latest Developments
7.5 Merck KGaA
7.5.1 Merck KGaA Company Summary
7.5.2 Merck KGaA Business Overview
7.5.3 Merck KGaA Male Hypogonadism Therapy Major Product Offerings
7.5.4 Merck KGaA Male Hypogonadism Therapy Revenue in Global Market (2018-2023)
7.5.5 Merck KGaA Key News & Latest Developments
7.6 Mylan
7.6.1 Mylan Company Summary
7.6.2 Mylan Business Overview
7.6.3 Mylan Male Hypogonadism Therapy Major Product Offerings
7.6.4 Mylan Male Hypogonadism Therapy Revenue in Global Market (2018-2023)
7.6.5 Mylan Key News & Latest Developments
7.7 Bayer
7.7.1 Bayer Company Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Male Hypogonadism Therapy Major Product Offerings
7.7.4 Bayer Male Hypogonadism Therapy Revenue in Global Market (2018-2023)
7.7.5 Bayer Key News & Latest Developments
7.8 Teva
7.8.1 Teva Company Summary
7.8.2 Teva Business Overview
7.8.3 Teva Male Hypogonadism Therapy Major Product Offerings
7.8.4 Teva Male Hypogonadism Therapy Revenue in Global Market (2018-2023)
7.8.5 Teva Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Male Hypogonadism Therapy Major Product Offerings
7.9.4 Novartis Male Hypogonadism Therapy Revenue in Global Market (2018-2023)
7.9.5 Novartis Key News & Latest Developments
7.10 Abbott
7.10.1 Abbott Company Summary
7.10.2 Abbott Business Overview
7.10.3 Abbott Male Hypogonadism Therapy Major Product Offerings
7.10.4 Abbott Male Hypogonadism Therapy Revenue in Global Market (2018-2023)
7.10.5 Abbott Key News & Latest Developments
7.11 Roche
7.11.1 Roche Company Summary
7.11.2 Roche Business Overview
7.11.3 Roche Male Hypogonadism Therapy Major Product Offerings
7.11.4 Roche Male Hypogonadism Therapy Revenue in Global Market (2018-2023)
7.11.5 Roche Key News & Latest Developments
7.12 Endo International
7.12.1 Endo International Company Summary
7.12.2 Endo International Business Overview
7.12.3 Endo International Male Hypogonadism Therapy Major Product Offerings
7.12.4 Endo International Male Hypogonadism Therapy Revenue in Global Market (2018-2023)
7.12.5 Endo International Key News & Latest Developments
7.13 Ipsen
7.13.1 Ipsen Company Summary
7.13.2 Ipsen Business Overview
7.13.3 Ipsen Male Hypogonadism Therapy Major Product Offerings
7.13.4 Ipsen Male Hypogonadism Therapy Revenue in Global Market (2018-2023)
7.13.5 Ipsen Key News & Latest Developments
7.14 ANI Pharmaceuticals
7.14.1 ANI Pharmaceuticals Company Summary
7.14.2 ANI Pharmaceuticals Business Overview
7.14.3 ANI Pharmaceuticals Male Hypogonadism Therapy Major Product Offerings
7.14.4 ANI Pharmaceuticals Male Hypogonadism Therapy Revenue in Global Market (2018-2023)
7.14.5 ANI Pharmaceuticals Key News & Latest Developments
7.15 TherapeuticsMD
7.15.1 TherapeuticsMD Company Summary
7.15.2 TherapeuticsMD Business Overview
7.15.3 TherapeuticsMD Male Hypogonadism Therapy Major Product Offerings
7.15.4 TherapeuticsMD Male Hypogonadism Therapy Revenue in Global Market (2018-2023)
7.15.5 TherapeuticsMD Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Male Hypogonadism Therapy Market Opportunities & Trends in Global Market
Table 2. Male Hypogonadism Therapy Market Drivers in Global Market
Table 3. Male Hypogonadism Therapy Market Restraints in Global Market
Table 4. Key Players of Male Hypogonadism Therapy in Global Market
Table 5. Top Male Hypogonadism Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Male Hypogonadism Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Male Hypogonadism Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Male Hypogonadism Therapy Product Type
Table 9. List of Global Tier 1 Male Hypogonadism Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Male Hypogonadism Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Male Hypogonadism Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Male Hypogonadism Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Male Hypogonadism Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Male Hypogonadism Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Male Hypogonadism Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Male Hypogonadism Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Male Hypogonadism Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Male Hypogonadism Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Male Hypogonadism Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Male Hypogonadism Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Male Hypogonadism Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Male Hypogonadism Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Male Hypogonadism Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Male Hypogonadism Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Eli Lilly Company Summary
Table 31. Eli Lilly Male Hypogonadism Therapy Product Offerings
Table 32. Eli Lilly Male Hypogonadism Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Eli Lilly Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Male Hypogonadism Therapy Product Offerings
Table 36. Pfizer Male Hypogonadism Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. AbbVie Company Summary
Table 39. AbbVie Male Hypogonadism Therapy Product Offerings
Table 40. AbbVie Male Hypogonadism Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. AbbVie Key News & Latest Developments
Table 42. Novo Nordisk Company Summary
Table 43. Novo Nordisk Male Hypogonadism Therapy Product Offerings
Table 44. Novo Nordisk Male Hypogonadism Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Novo Nordisk Key News & Latest Developments
Table 46. Merck KGaA Company Summary
Table 47. Merck KGaA Male Hypogonadism Therapy Product Offerings
Table 48. Merck KGaA Male Hypogonadism Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Merck KGaA Key News & Latest Developments
Table 50. Mylan Company Summary
Table 51. Mylan Male Hypogonadism Therapy Product Offerings
Table 52. Mylan Male Hypogonadism Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Mylan Key News & Latest Developments
Table 54. Bayer Company Summary
Table 55. Bayer Male Hypogonadism Therapy Product Offerings
Table 56. Bayer Male Hypogonadism Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Bayer Key News & Latest Developments
Table 58. Teva Company Summary
Table 59. Teva Male Hypogonadism Therapy Product Offerings
Table 60. Teva Male Hypogonadism Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Teva Key News & Latest Developments
Table 62. Novartis Company Summary
Table 63. Novartis Male Hypogonadism Therapy Product Offerings
Table 64. Novartis Male Hypogonadism Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Novartis Key News & Latest Developments
Table 66. Abbott Company Summary
Table 67. Abbott Male Hypogonadism Therapy Product Offerings
Table 68. Abbott Male Hypogonadism Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Abbott Key News & Latest Developments
Table 70. Roche Company Summary
Table 71. Roche Male Hypogonadism Therapy Product Offerings
Table 72. Roche Male Hypogonadism Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Roche Key News & Latest Developments
Table 74. Endo International Company Summary
Table 75. Endo International Male Hypogonadism Therapy Product Offerings
Table 76. Endo International Male Hypogonadism Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Endo International Key News & Latest Developments
Table 78. Ipsen Company Summary
Table 79. Ipsen Male Hypogonadism Therapy Product Offerings
Table 80. Ipsen Male Hypogonadism Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Ipsen Key News & Latest Developments
Table 82. ANI Pharmaceuticals Company Summary
Table 83. ANI Pharmaceuticals Male Hypogonadism Therapy Product Offerings
Table 84. ANI Pharmaceuticals Male Hypogonadism Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. ANI Pharmaceuticals Key News & Latest Developments
Table 86. TherapeuticsMD Company Summary
Table 87. TherapeuticsMD Male Hypogonadism Therapy Product Offerings
Table 88. TherapeuticsMD Male Hypogonadism Therapy Revenue (US$, Mn) & (2018-2023)
Table 89. TherapeuticsMD Key News & Latest Developments
List of Figures
Figure 1. Male Hypogonadism Therapy Segment by Type in 2022
Figure 2. Male Hypogonadism Therapy Segment by Application in 2022
Figure 3. Global Male Hypogonadism Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Male Hypogonadism Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Male Hypogonadism Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Male Hypogonadism Therapy Revenue in 2022
Figure 8. By Type - Global Male Hypogonadism Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Male Hypogonadism Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Male Hypogonadism Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Male Hypogonadism Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Male Hypogonadism Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Male Hypogonadism Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Male Hypogonadism Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Male Hypogonadism Therapy Revenue Market Share, 2018-2029
Figure 16. US Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Male Hypogonadism Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Male Hypogonadism Therapy Revenue Market Share, 2018-2029
Figure 28. China Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Male Hypogonadism Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Male Hypogonadism Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Male Hypogonadism Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Eli Lilly Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AbbVie Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novo Nordisk Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Merck KGaA Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Mylan Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bayer Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Teva Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Novartis Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Abbott Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Roche Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Endo International Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Ipsen Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. ANI Pharmaceuticals Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. TherapeuticsMD Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
